Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, “After decades with only one option, new therapies emerge for congenial ...

This is a preview. Log in through your library . Abstract Over the last two decades, we have extensively studied the genetics of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency (CAH ...

Hormonal measurements and HLA genotyping of amniotic fluid at midgestation correctly predicted the postnatal dx of CAH in 26 of 29 fetuses at risk for CAH. Of these 26, 6 were predicted to have ...

September 13, 2010 — Universal newborn screening is recommended for congenital adrenal hyperplasia (CAH), according to the new Clinical Practice Guideline from The Endocrine Society, published in the ...

Steroid biosynthesis is affected in the AR disorder known as congenital adrenal hyperplasia (CAH): the majority of cases are due to 21-hydroxylase deficiency. Androgen excess affects women’s ...

New CAHtalyst™ Pediatric and CAHtalyst™ Adult Phase 3 Clinical Study Data in Congenital Adrenal Hyperplasia CAHtalog™ Registry Data Highlighting Impact of Supraphysiologic Glucocorticoid Dosing Phase ...

The traditional view of nonclassic congenital adrenal hyperplasia is that affected individuals are not glucocorticoid-deficient. The results of a French study now cast doubts on this assumption, ...

- CAHtalyst™ Adult Phase 3 Study Met Primary and Important Key Secondary Endpoints, with Crinecerfont Treatment Decreasing Androstenedione Levels and Enabling Glucocorticoid Dose Reduction While ...

New, Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, Proceedings of the National Academy of Sciences of the United States of America, Vol.

A new study of the largest international cohort of 108 patients with congenital adrenal hyperplasia (CAH) due to 11β-hydroxylase deficiency sheds light on the characteristics of this rare genetic ...